Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Landau

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Frontiers in Cardiovascular Medicine|June 14, 2024
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI studyEthan Katznelson, Michael Jerosch-Herold, Sarah A M Cuddy, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
American Journal of Hematology|May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myelomaAnita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Bone Marrow Transplantation|November 21, 2021
A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patientsCarlyn Rose Tan, Noel Estrada-Merly, Heather Landau, et al.
Bone Marrow Transplantation|June 22, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020Ben Lerman, Stefan Schönland, Ute Hegenbart, et al.
Blood Cancer Journal|October 13, 2025
Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myelomaTara Sebastian, Sridevi Rajeeve, Tasmin Farzana, et al.
JACC. Cardiovascular Imaging|May 18, 2020
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?Sarah A M Cuddy, Paco E Bravo, Rodney H Falk, et al.
European Heart Journal. Cardiovascular Imaging|January 9, 2024
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosisYesh Datar, Olivier F Clerc, Sarah A M Cuddy, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Frontiers in Cardiovascular Medicine|June 14, 2024
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI studyEthan Katznelson, Michael Jerosch-Herold, Sarah A M Cuddy, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Blood Cancer Journal|February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Blood Cancer Journal|December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myelomaVenkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
American Journal of Hematology|May 14, 2022
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myelomaAnita D'Souza, Ruta Brazauskas, Edward A Stadtmauer, et al.
Bone Marrow Transplantation|November 21, 2021
A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patientsCarlyn Rose Tan, Noel Estrada-Merly, Heather Landau, et al.
Bone Marrow Transplantation|June 22, 2026
Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020Ben Lerman, Stefan Schönland, Ute Hegenbart, et al.
Blood Cancer Journal|October 13, 2025
Correction: Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myelomaTara Sebastian, Sridevi Rajeeve, Tasmin Farzana, et al.
JACC. Cardiovascular Imaging|May 18, 2020
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?Sarah A M Cuddy, Paco E Bravo, Rodney H Falk, et al.
European Heart Journal. Cardiovascular Imaging|January 9, 2024
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosisYesh Datar, Olivier F Clerc, Sarah A M Cuddy, et al.
Pageof 10